EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B

Estimating the world cancer burden: Globocan 2000

2001 • 3,781 citations

Liver Biopsy

2001 • 1,920 citations

Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children

1997 • 1,836 citations

A One-Year Trial of Lamivudine for Chronic Hepatitis B

1998 • 1,779 citations

Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels

2002 • 1,415 citations

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

2003 • 1,354 citations

Liver Transplantation in European Patients with the Hepatitis B Surface Antigen

1993 • 1,040 citations

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

2003 • 1,016 citations

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1993 • 1,011 citations

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

2000 • 940 citations

Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier State

1985 • 823 citations

Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B

1996 • 821 citations

PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE

1983 • 810 citations

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

1998 • 808 citations

Management of hepatitis B: 2000—Summary of a workshop

2001 • 789 citations

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

2002 • 709 citations

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

2000 • 708 citations

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

2001 • 641 citations

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

1999 • 634 citations

Hepatitis B e antigen–negative chronic hepatitis B

2001 • 564 citations

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”?

2001 • 559 citations

Impact of hepatitis B and C virus on kidney transplantation outcome

1999 • 542 citations

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

2000 • 503 citations

Guidelines on the use of liver biopsy in clinical practice

1999 • 482 citations

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1999 • 450 citations

The Changing Epidemiology of Hepatitis B in the United States

1990 • 446 citations

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men

1999 • 436 citations

Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus

2001 • 435 citations

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1998 • 434 citations

Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease

2001 • 428 citations

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

2000 • 426 citations

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

2000 • 422 citations

Natural history and prognostic factors for chronic hepatitis type B.

1991 • 415 citations

Hepatitis B: An important public health issue

2000 • 399 citations

Global programme for control of hepatitis B infection

1995 • 395 citations

Long-Term Therapy of Chronic Hepatitis B With Lamivudine

2000 • 355 citations

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1997 • 348 citations

Hepatitis B e Antigen Seroconversion After Lamivudine Therapy Is Not Durable in Patients With Chronic Hepatitis B in Korea

2000 • 343 citations

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

2002 • 335 citations

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

1987 • 333 citations

Treatment of Chronic Hepatitis D with Interferon Alfa-2a

1994 • 317 citations

Clinical Trial of Lamivudine in Children with Chronic Hepatitis B

2002 • 315 citations

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

2002 • 306 citations

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

1994 • 305 citations

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

1999 • 300 citations

Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C

1998 • 298 citations

The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers

1993 • 296 citations

Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study

1991 • 294 citations

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

1997 • 293 citations

Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation

1999 • 291 citations

Incidence and Risk Factors for Acute Hepatitis B in the United States, 1982–1998: Implications for Vaccination Programs

2002 • 282 citations

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

2002 • 269 citations

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults

1987 • 268 citations

Clinical significance of hepatitis B virus genotypes

2002 • 256 citations

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

1998 • 254 citations

Molecular diagnosis of viral hepatitis

2002 • 250 citations

The long-term course of chronic hepatitis B

1999 • 245 citations

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1992 • 242 citations

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1989 • 229 citations

Seroepidemiology of Hepatitis B Virus Infection in Children

1996 • 229 citations

Virologic and Clinical Expressions of Reciprocal Inhibitory Effect of Hepatitis B, C, and Delta Viruses in Patients With Chronic Hepatitis

2000 • 218 citations

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

2002 • 210 citations

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1993 • 206 citations

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease

2002 • 206 citations

Evolution of Hepatitis B Virus Polymerase Gene Mutations in Hepatitis B E Antigen-Negative Patients Receiving Lamivudine Therapy

2000 • 203 citations

Hepatitis B–Related Sequelae

1990 • 192 citations

Progress Toward the Elimination of Hepatitis B Virus Transmission Among Health Care Workers in the United States

1997 • 192 citations

Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation

2002 • 190 citations

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

1995 • 182 citations

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen

2001 • 181 citations

Effects of Lamivudine on Replication of Hepatitis B Virus in HIV-Infected Men

1996 • 175 citations

Chemotherapy and Bone Marrow Transplantation for Cancer Patients Who Are Also Chronic Hepatitis B Carriers: A Review of the Problem

1999 • 170 citations

Tenofovir Disoproxil Fumarate Therapy for Chronic Hepatitis B in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Individuals for Whom Interferon‐α and Lamivudine Therapy Have Failed

2002 • 162 citations

Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program

2000 • 159 citations

Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR)

1999 • 150 citations

Fulminant hepatic failure

1997 • 147 citations

Immunoprophylaxis of Infection with Hepatitis B Virus in Infants Born to Hepatitis B Surface Antigen-Positive Carrier Mothers

1985 • 141 citations

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons

1992 • 139 citations

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

1988 • 138 citations

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)

2001 • 126 citations

Changing pattern of chronic hepatitis D in Southern Europe

1999 • 123 citations

HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C

2002 • 123 citations

Viral Infections of Humans

1997 • 110 citations

The Emergence of Hepatitis B as a Sexually Transmitted Disease

1990 • 103 citations

Natural history of hepatitis B virus infection in children

2000 • 103 citations

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

2002 • 98 citations

Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B*1

1995 • 96 citations

Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

2002 • 95 citations

Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus

2001 • 92 citations

Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study

2000 • 89 citations

Perinatal transmission of hepatitis B virus in highincidence countries

1987 • 87 citations

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

1993 • 83 citations

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results of a pilot study

2001 • 82 citations

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta‐analysis

2001 • 79 citations

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

2001 • 74 citations

Advances in hepatitis D virus biology and disease.

1994 • 66 citations

Perinatal transmission of hepatitis B virus and its prevention

2000 • 58 citations

Economic evaluation of the societal costs of hepatitis B in South Korea

2001 • 43 citations

Blood-borne pathogens and nosocomial infections

2002 • 42 citations

Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection

2001 • 39 citations

Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B.

1998 • 34 citations

Risk of HIV and Other Blood‐Borne Infections in the Cardiac Setting

2001 • 31 citations

Immunoprophylaxis of perinatal transmission of the hepatitis B virus: Efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low‐prevalence area

1986 • 30 citations

The economic burden of hepatitis B in Germany.

2000 • 27 citations

Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis

1995 • 26 citations

Hepatitis B and C in the Liver Transplant Recipient

2000 • 23 citations

Practice Guidelines for Liver Biopsy

2000 • 19 citations

Health care costs associated with chronic hepatitis B

1999 • 17 citations

Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?

2002 • 14 citations

Hepatitis viruses and the safety of blood donations

1999 • 14 citations

Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the Newly Independent States

2002 • 13 citations

Passive and active immunization against hepatitis B virus infection: optimal scheduling in healthy young adults.

1989 • 9 citations

Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors

2002 • 7 citations